BOSTON SCIENTIFIC CORP
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 9B. OTHER INFORMATION
(b)
On November 13, 2025, Miriam O’Sullivan, our Senior Vice President and Chief Human Resources Officer, entered into atrading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Ms. O’Sullivan’s plan covers the sale of 14,912 shares of our common stock to be acquired upon exercise of stock options. Transactions under Ms. O’Sullivan’s plan are based upon pre-established dates and stock price thresholds and will only occur upon the expiration of the applicable mandatory cooling-off period. Ms. O’Sullivan’s plan will terminate on the earlier of December 31, 2026, or the date all shares subject to the plan have been sold.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.